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Abstract
Many carcinogenic polycyclic aromatic hydrocarbons (PAHs) and their metabolites can bind covalently to DNA. Carcinogen-
DNA adducts may lead to mutations in critical genes, eventually leading to cancer. In this study we report that fish oil (FO)
blocks the formation of DNA adducts by detoxification of PAHs. B6C3F1 male mice were fed a FO or corn oil (CO) diet for 30
days. The animals were then treated with seven carcinogenic PAHs including benzo(a)pyrene (BaP) with one of two doses
via a single intraperitoneal injection. Animals were terminated at 1, 3, or 7 d after treatment. The levels of DNA adducts were
analyzed by the
32P-postlabeling assay. Our results showed that the levels of total hepatic DNA adducts were significantly
decreased in FO groups compared to CO groups with an exception of low PAH dose at 3 d (P=0.067). Total adduct levels in
the high dose PAH groups were 41.3666.48 (Mean6SEM) and 78.7268.03 in 10
9 nucleotides (P=0.011), respectively, for
the FO and CO groups at 7 d. Animals treated with the low dose (2.5 fold lower) PAHs displayed similar trends. Total adduct
levels were 12.2162.33 in the FO group and 24.0761.99 in the CO group, P=0.008. BPDE-dG adduct values at 7 d after
treatment of high dose PAHs were 32.3461.94 (CO group) and 21.8263.37 (FO group) in 10
9 nucleotides with P value being
0.035. Low dose groups showed similar trends for BPDE-dG adduct in the two diet groups. FO significantly enhanced gene
expression of Cyp1a1 in both the high and low dose PAH groups. Gstt1 at low dose of PAHs showed high levels in FO
compared to CO groups with P values being 0.014. Histological observations indicated that FO played a hepatoprotective
role during the early stages. Our results suggest that FO has a potential to be developed as a cancer chemopreventive
agent.
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Introduction
According to the World Health Organization, cancer is a leading
cause of death worldwide. It accounted for 7.6 million deaths
(around 13% of all deaths worldwide) in 2008 [1]. In United States,
a total of 1,529,560 new cancer cases and 569,490 deaths from
cancer were projected to occur in the United States in 2010 [2].
Epidemiological and experimental data show that most cancers are
caused by environmental factors, including exposure to complex
mixtures such as carcinogenic polycyclic aromatic hydrocarbons
(PAHs) from cigarette smoke, air and water pollution [3]. Several
PAHs have been listed by the U.S. EPA as probable human
carcinogens [4]. PAHs exhibit their biological effects through
metabolic activation by cytochrome P450 (CYP) enzymes to
electrophilic species that are capable of reacting with nucleophilic
sites of DNA to form adducts. Such pre-mutagenic lesions play
essential roles in the initiation stage of carcinogenesis [5,6].
A prospective cohort study, reported by Tang et al [7], showed
that healthy current smokers who had elevated levels of aromatic
DNA adducts in white blood cells were approximately three times
more likely to be diagnosed with lung cancer one to thirteen years
later than current smokers with lower adduct levels. Bak et al. [8]
obtained similar epidemiological results in Denmark. Animal
(B6C3F1 male mice) experiments have also shown significant
positivecorrelationsbetween levels ofDNAadductsinducedbyBaP
or complex PAHs mixtures at 1, 3, and 7 days after treatment and
tumor incidence observed after 10 months [9]. Therefore, decreases
in carcinogen-DNA adduct levels by appropriate approaches,
including using chemopreventive agents, is expected to lower tumor
yields. Since most cancers are still not curable, cancer prevention,
especially in initiation phase of carcinogenesis is much more
desirable than that during the phases of promotion and progression.
Recently, natural chemopreventive agents have received great
attention for cancer prevention because of their various health
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Chemopreventive agents may inhibit adduct formation or remove
adductednuleotidesand damagedcellsthroughseveralpathways:1)
metabolic inactivation of chemical carcinogens [11,12]; 2) enhance-
ment of DNA repair [13]; and 3) induction of cellular apoptosis
[14,15]. Previous experiments have shown that dietary fish oil (FO)
with major components of n-3 fatty acids decreases oxidative DNA
lesions by enhancing apoptosis in rat colon [16,17]. It has been
reported that oxidation of n-3 fatty acids can induce Nrf2-based
antioxidant and phase II detoxification defense systems [18].
Mernitz et al reported that FO inhibits NNK-induced lung
carcinogenesis in the A/J mouse [19]. It has also been reported
that dietary FO suppresses tumor growth and metastasis [20]. Fat-1
transgenic mice (convert n-6 to n-3 fatty acids) [21] displayed a
decrease in tumor formation in the diethylnitrosamine induced liver
tumor model compared to wild-type littermates [22]. Liver Cox-2
expression was markedly lower in these fat-1 mice [22]. Lim et al
reported that n-3 fatty acids inhibit hepatocellular carcinoma cell
growth through blocking b-catenin and Cox-2 [23].
In this investigation, we have tested the hypothesis that levels of
carcinogenic PAH-DNA adducts can be diminished by dietary
FO. The mechanisms of attenuation of DNA adducts by dietary
FO have been also investigated.
Materials and Methods
Ethics Statement
Animal experiments were carried out in strict accordance with
the principles and procedures of the Guide for the Care and Use of
Laboratory Animals. The protocol was approved by the
Institutional Animal Care and Use Committee, Texas A&M
University System Health Science Center (Protocol Number:
06001-R1).
Chemicals
Benzo(a)pyrene (BaP), benz(a)anthracene (BA), chrysene, ben-
zo(b)fluoranthene (BbF), benzo(k)fluoranthene (BkF), and diben-
z(a,h)anthracene (DBA) were obtained from Sigma-Aldrich (St.
Louis, MO). Indeno(1,2,3-c,d)pyrene (IP) was purchased from
Absolute Standards (Hamden, CT). Materials for DNA extraction
[24,25,26,27], RNA extraction [28], and
32postlabeling analysis
[24,29,30] have been reported previously.
Animals
B6C3F1 male mice (4–5 weeks) were obtained from Harlan
Sprague Dawley (Houston). A total of 70 animals were initially
housed in the Program for Animal Resources of the Institute of
Biosciences and Technology, Texas A&M University Syetem.
Diets
FO and CO diets were purchased from Dytes Inc. (Bethlehem,
PA). All diets contained 15% lipid by weight (Table 1). Menhaden
fish oil was provided by Omega Protein Inc. (Houston, TX). The
fatty acid compositions of FO and CO are listed in Table 2. In
order to meet essential fatty acid requirements, the FO diet
contained 3.5 g of corn oil/100 g of diet [31,32]. To prevent
formation of oxidized lipids, the diet was stored at 220uC in the
dark. The FO and CO diets contained identical levels of a-
tocopherol (0.15%), c-tocopherol (0.1%) and tertiarybutylhydro-
quinine (0.025%) as antioxidants.
Animal experiments
Mice were housed in cages in a temperature and humidity
controlled facility with a daily photoperiod of 12 hours light and
12 hours dark. Animals were acclimatized for a week to the new
environment during which the mice consumed a standard pelleted
diet, and the mice were randomly allocated to one of the two
experimental diet groups. Mice had free access to water and fresh
diet was provided in clean food bowls daily. After 30 days of
consuming the experimental diets (FO or CO), 35 animals were
randomized into 7 groups of 5 mice each for each diet. Then 15
mice for each diet were intraperitioneally (ip) injected with a
mixture of high dose PAHs, i.e. BaP, 1.72 mg; BA, 5.25 mg;
chrysene, 5.25 mg; BbF, 2.15 mg; BkF, 1.33 mg; DBA, 0.11 mg and
IP, 0.67 mg for 20 g body weight. Another 15 mice for each diet
received low dose PAHs. These chemicals and their concentrations
were similar to the residues extracted from contaminated soils of
SuperFund Sites [9]. The concentrations of low dose PAHs were
proportionally reduced by 2.5 fold from high dose PAHs mixture.
These chemicals were dissolved in dimethyl sulfoxide (DMSO):-
corn oil (50:50). Vehicle volume for ip injection was 7 ml per g
body weight. Animals were fed same diet after treatment and were
euthanized by CO2 asphyxiation and cervical dislocation at 1, 3,
and 7 d after the PAH treatment. Five mice served as a control for
each diet and therefore, were injected with vehicle. Liver tissues
were collected and were frozen in liquid nitrogen immediately and
then stored at 280uC until extractions of DNA and RNA. Part of
each tissue was fixed in paraformaldehyde (4%) for histological
examination.
Analyses of DNA adducts
DNA extraction and
32P-postlabeling analyses were performed
as in previous experiments [32]. DNA was isolated by solvent
extraction combined with enzymatic digestion of protein and RNA
[26,27] and stored at 280uC until analysis. The nuclease P1-
enhanced bisphosphate version of the
32P-postlabeling method
[24] was used for analysis, with modifications of the chromato-
graphic conditions [33]. Briefly, DNA (10 mg) was enzymatically
degraded to normal (Np) and modified (Xp) deoxyribonucleoside
39-monophosphates with micrococcal nuclease and spleen phos-
phodiesterase at pH 6.0 and 37uC for 3.5 h. After treatment of the
mixture with nuclease P1 to convert normal nucleotides to
nucleosides, modified nucleotides (Xp) were converted to 59-
32P-
labeled deoxyribonucleoside 39,59-bisphosphates (pXp) by incuba-
tion with carrier-free [c-
32P]ATP and polynucleotide kinase.
Radioactively labeled digests were applied to modified poly-
ethyleneimine (PEI)-cellulose thin layers and chromatographed
overnight (15–16 h) with 2.3 M sodium phosphate, pH 5.75 (D1),
to purify bulky adducts. Labeled PAH-adducts retained in the
lower (L, 2.861.0 cm) part of the D1 chromatogram were, after
Table 1. Diet composition.
Ingredients Fish Oil Diet (%) Corn Oil Diet (%)
Dextrose 51.05 51.05
Casein 22.35 22.35
DL-Methionine 0.34 0.34
Corn Oil 3.50 15.00
Fish Oil (Menhaden) 11.50 0
Mineral mix, AIN-76, Harlan Teklad 3.91 3.91
Vitamin mix, AIN 76-A, Harlan Teklad 1.12 1.12
Choline bitartrate 0.22 0.22
Pectin 6.00 6.00
doi:10.1371/journal.pone.0026589.t001
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transferred to individual acceptor sheets and resolved by two-
dimensional thin-layer chromatography (TLC). The bulky DNA
adducts were separated with 3.82 M lithium formate, 6.75 M
urea, pH 3.35 and 0.72 M sodium phosphate, 0.45 M Tris–HCl,
7.65 M urea, pH 8.2 in the first (D3) and second (D4) dimensions,
respectively.
32P-labeled DNA adducts were visualized by screen-
enhanced autoradiography at 280uC using Kodak XAR-5 film or
with the aid of an InstantImager (Packard Instruments) [25].
Appropriate blank count rates were automatically subtracted by
the instrument from sample values. The extent of covalent DNA
modification was calculated from corrected sample count rates.
Quantitative data represented minimum estimates because 100%
recovery presumably was not achieved. Statistical analysis of the
data from individual mice was performed by using the unpaired
and paired Student’s t-tests [34].
Quantitative reverse-transcription PCR
TaqManH Gene Expression Assays were used to determine gene
expression changes for selected detoxification genes. Gene-specific
probes and primer sets were purchased from Applied Biosystems
(Foster City, CA). The assays were performed according to
manufacturer’s protocol on an ABI PRISMH 7900 HT Sequence
Detection System (Applied Biosystems, Foster City, CA). Data
were analyzed using SDS software v2.1 (Applied Biosystems,
Foster City, CA). Mouse Gapdh gene was used as house-keeping
control for quantitative RT-PCR because it exhibited consistent
normalized intensity across all arrays. Relative standard curve
method was used to generate quantitative values. Each reaction
was replicated three times and the normalized mean value was
used in the final comparisons. In order to compare the levels of
gene expression in liver between two diet groups with an unpaired
T-test, Ct values were converted by the formula: 2‘(2(Ct value 2
b-actin value 2 a constant)).
Histological examination
The animals were euthanized by CO2 asphyxiation and cervical
dislocation. The livers were removed for various analyses. Part of
each tissue was fixed in 4% paraformaldehyde, following which
the samples were embedded in paraffin and cut into 5 mm thick
sections. The tissue section on glass slide was stained with
hematoxylin and eosin (H&E).
Results
Diet consumption and body weights
B6C3F1 male mice were fed dietary FO or CO for 30 days
before treatment with PAH mixture. During the experiment, diet
consumption was measured daily. Average daily diet consumption
was 2.9660.034 g (mean 6 SEM) and 3.0160.028 g per mouse
for FO and CO groups, respectively. The differences were not
significant (P.0.05). The body weights were determined weekly.
Dietary FO did not significantly affect the body weights compared
to CO group (Table 3).
Effects of dietary fish oil on PAH-DNA adducts
Liver DNA from mice fed with dietary FO or CO exhibited
qualitatively similar profiles of DNA adducts (Figure 1). This
typical pattern displayed that BPDE-dG [35] was the major
adduct.
Hepatic DNA adducts were formed within 24 h after treatment
of PAH mixture. High levels of PAH adducts persisted from 24 h
till 7 d after treatment. Overall, DNA adducts displayed the
highest levels at 1 d time point. The levels of DNA adducts were
then decreased at the 3 and 7 d time points in both dietary groups
(Figures 2 and 3). The levels of BPDE-dG and total DNA adducts
(spots 1–5, Figure 1) in livers of mice were much higher in CO
groups compared to corresponding FO groups at all time points.
Dietary FO decreased levels of total PAH adducts by 30–49%
Table 2. Fatty acids in fish oil and corn oil.
Fish Oil Corn Oil
Fatty acid Weight (%) Fatty acid Weight (%) Fatty acid Weight (%) Fatty acid Weight (%)
14:0 9.0 18:0 2.8 20:5 (n-3) 15.5 14:0 Trace
15:0 0.7 18:1 11.4 21:5 (n-3) 0.8 16:0 10.8
16:0 17.1 18:2 (n-6) 1.5 22:1 0.5 16:1 Trace
16:1 12.5 18:3* 1.4 22:4 (n-6) 0.4 18:0 2.1
16:2 1.7 18:4 (n-3) 3.5 22:5 (n-3) 2.4 18:1 26.5
16:3 1.7 20:0 0.2 22:6 (n-3) 9.1 18:2 (n-6) 60.0
16:4 (n-3) 1.8 20:1 1.6 24:1 0.1 18:3*** 0.6
17:0 0.9 20:3 (n-6) 0.4 Unknown 0.2 Total 100
17:1 0.5 20:4** 2.3 Total 100
*n-3=0.99%, n-6=0.41%;
**n-3=1.4%, n-6=0.9%;
***n-3/n-6.
doi:10.1371/journal.pone.0026589.t002
Table 3. Mouse body weights.
Time Corn Oil Fish Oil P
Mean SEM Mean SEM
Day 0 21.53 0.19 21.53 0.16 .0.05
Day 7 23.89 0.22 23.86 0.20 .0.05
Day 14 26.09 0.25 25.94 0.21 .0.05
Day 21 28.02 0.25 28.19 0.25 .0.05
Day 28 29.82 0.31 30.49 0.26 .0.05
n=35.
doi:10.1371/journal.pone.0026589.t003
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adduct levels in FO groups were attenuated by 26–47% (Figure 3).
Although FO groups showed lower levels of DNA adducts at all
time points in both PAH doses compared to CO groups, the
significant differences in both BPDE-dG and total adduct levels
were only observed at 7 d time point. At high PAH dose, the
values of total hepatic DNA adducts were 78.7268.03 (mean6-
SEM) and 41.3566.48 in 10
9 nucleotides for CO and FO groups,
respectively. The P value was 0.011 (Figure 2). The levels of
BPDE-dG adducts were 32.3461.94 (CO group) and 21.8263.37
(FO group) in 10
9 nucleotides with P value being 0.035 (Figure 3).
Low dose PAH groups displayed similar trends for both BPDE-dG
and total adducts. Interestingly, at 1 d time point, total DNA
adducts displayed significant differences between CO and FO
groups (Figure 2). However, no significant differences of BPDE-dG
levels were observed between two diet groups, although FO
showed trends of lower adduct levels compared to CO. At 3 d time
point, total adduct levels at high PAH dose group, but not low
dose, displayed significant difference between two diet groups. The
levels of DNA adducts were 72.5867.71 for CO group and
44.9963.82 for FO group (P=0.018). FO decreased level of DNA
adducts by 38% (Figure 2). BPDE-dG adduct at low PAH dose
group, but not high dose, showed similar results with value of
adducts being 20.9062.53 and 12.7361.55 for CO and FO
groups, respectively. P value was 0.033 (Figure 3). Overall, BPDE-
dG and total adducts were diminished by dietary FO in both high
and low dose PHA groups (Figures 2 and 3). Taking all the groups
of different treatments and time points together, dietary FO
showed tremendous effects on the formation of DNA adducts
(Table 4). Paired t-test displayed very significant lowering of PAH
adducts in FO groups compared with CO groups. P values were
0.0008 and 0.0048 for BPDE-dG and total adducts, respectively.
Effects of dietary fish oil on gene expression of phase I
and II enzymes
In order to understand the mechanisms that may contribute to
the decreased levels of DNA adducts, including chemical
detoxification, DNA repair and apoptosis, which are enhanced
by FO, gene expression was analyzed by Real-time RT-PCR.
Gene expression of phase I and II enzymes Cyp1a1, Cyp1b1, Gstt1,
and Gstm1 in hepatic RNA of mice at 7 d time point was
determined by TaqManH Gene Expression assays. FO signifi-
cantly enhanced activities of Cyp1a1 (DD Ct method) compared to
CO in both low and high doses of PAH treated groups (Table 5).
Gstt1 expression was only enhanced by FO at low dose of PAH
group. In contrast, Cyp1b1 and Gstm1 did not significantly change
as dramatically as Cyp1a1 and Gstt1 between the two diet groups.
DNA repair and apoptosis related genes, Dclre1a, Ercc1, and Casp3,
in the liver of 7 d time point mice were also determined by Real-
time RT-PCR. There were no significant differences in hepatic
Figure 1. Typical representative pattern of
32P-postlabeled
PAH-DNA adducts in mouse liver. Mice, fed with dietary FO, were
treated with high dose of PAH mixture. Animals were terminated at 7
days after treatment.
doi:10.1371/journal.pone.0026589.g001
Figure 2. Comparison of the levels of total DNA adducts in liver
of mice between two diet groups. Mice were treated with high or
low dose of PAH mixtures. Animals were terminated at 1, 3 or 7 days
after treatment. Overall, dietary FO decreased the levels of PAH adducts
compared to CO groups. Except for low PAH dose at 3 days, the
differences of adduct values between two diet groups were significant.
Mean 6 SEM, n=4.
doi:10.1371/journal.pone.0026589.g002
Figure 3. Comparison of the levels of BPDE-dG adduct in liver
of mice between the two diet groups. FO significantly reduced the
levels of BPDE-dG adducts at 3 (low PAH dose only) or 7 day time
points. For animal treatment information, please see Figure 2. Mean 6
SEM, n=4.
doi:10.1371/journal.pone.0026589.g003
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shown). Gene expression of Gstt1 and Gstm1 was also analyzed for
1 and 3 d time points. However, no significant differences were
observed between CO and FO.
Hepatic toxicity induced by PAHs
Sections from control mice in both diet groups display normal
hepatic architecture and hepatocytes (Figure 4A and 4D).
Significant liver damage was observed in CO groups of mice
treated with high dose PAHs at 7 d (Figure 4B), but not in FO
(Figure 4E). Figure 4B shows that liver tissue consists of focal
hemorrhage and necrosis. No sharp boundaries between the cords
of hepatocytes and sinusoids are observed (Figure 4B). Histological
examinations were also carried out for 1 and 3 d tissue samples.
There was no hepatic damage observed in either the FO or CO
group. This important histological observation indicated that FO
played a hepatoprotective role in early stage.
Discussion
Complex PAH mixtures are ubiquitous carcinogenic environmen-
tal contaminants to which humans are exposed every day. DNA
adducts have been proven to be significant biomarkers for
carcinogenic PAH exposure in many tissues of human [36], especially
in smokers [5]. Previous animal experiments have indicated that
levels of carcinogen DNA adducts correlated with tumor incidence in
rodents [9,37]. Epidemiological studies have also shown there were
significant positive association between levels of PAH-DNA adducts
levelsand tumor incidence [7,8,38]. Therefore, it is very important to
develop approaches that can decrease the formation of DNA adducts
and can remove adducted nucleotides and damaged cells with DNA
adducts. These strategies are expected to significantly reduce the risk
of cancer, especially in high risk populations such as cigarette smokers
and others exposed to environmental PAHs.
Our experiments have indicated that mice on a FO diet displayed
lower hepatic PAH-DNA adduct levels from 1 through 7 d after PAH
treatment compared to CO groups. Significant differences of total
adduct levels (Figure 2) between the two diet groups were observed in all
time points and doses, except for low PAH dose at 3 d (P=0.067).
BPDE-dG adduct (Figure 3) displayed slightly different trends
compared with total DNA adducts. No significant differences of
BPDE-dG were observed at 1 d between two diet groups. At 3 d, FO
decreased BPDE-dG significantly (P=0.033) in low PAH dose group
only. FO groups displayed significant lower levels of BPDE-dG in both
PAH doses at 7 d compared to CO (Figure 3). These results suggested
t h a ti tm a yt a k em o r et i m ef o rF Ot oi n h i b i tf o r m a t i o no fB P D E - d G
adducts than to decrease levels of other DNA adducts. At the 7 d time
point, both levels of PAH-DNA adducts and expression of Cyp1a1 gene
displayed very significant differences between the FO and CO groups.
Gstt1 exhibited similar trend but only low PAH dose groups showed
s i g n i f i c a n td i f f e r e n c e( T a b l e5 ) .T h e s eo b s e r v a t i o n ss u g g e s tt h a tF O ,
with major components as n-3 fatty acids, may act as chemopreventive
agents to attenuate carcinogen-DNA adduct formation.Subsequently, it
may reduce the risk of cancer of liver in subjects exposed to PAH
carcinogens. Many studies have reportedthat n-3 fattyacids played very
important roles in cancer prevention [39,40]. It was also reported that
frequent fresh fish consumption may reduce the risk of lung cancer [41].
In 1985, Wattenberg pointed out [42] that chemopreventive
agents can be classified into two major group: blocking agents and
suppressing agents. Blocking agents prevent carcinogenic com-
pounds from reacting with critical target sites in the tissue.
Suppressing agents act after attack by carcinogens [12,42,43].
Some agents have both effects.
In the current study, we found that FO could play a role in
detoxifying carcinogenic PAHs by mechanisms entailing induction
of phase II enzymes and/or Cyp1a1. This was supported by
histological results (Figure 4). The hepatic toxicity by PAHs was
obviously attenuated in FO group at 7 d. Therefore, we believe
that FO may play a role as a blocking agent in our current study. It
is possible that Cyp1a1 and Gstt1genes, and possibly other related
genes that we did not analyze this time, may have been involved in
the detoxification of PAHs. Although Cyp1a1 is known to be
involved in metabolic activation of PAHs to reactive intermediates,
recent studies have suggested that Cyp1a1 also contributes to the
detoxification of BaP [44,45]. In the current study, it is quite
possible that induction of Cyp1a1 in part contributed to the
decrease of PAH-DNA adduct formation by FO. Glutathione S-
transferases (GSTs) are a class of phase II enzymes, which can
detoxify PAH epoxides as well as quinones, and hydroperoxides by
conjugation with gluthathione [46,47]. The induction of Gsst1 by
FO may also have contributed to the decreased PAH-DNA adduct
levels in mice fed with FO diet.
Table 4. Comparison of levels of DNA adducts in livers of
male mice treated with mixtures of carcinogenic PAHs
between two diets (adducts in 10
9 nucleotides).
Time Chemical Dose BPDE-dG Adduct Total DNA adducts
CO FO P CO FO P
1 day PAHs High 38.55 28.48 0.0008 80.49 52.35 0.0048
Low 23.89 16.59 46.07 30.63
3 day PAHs High 40.48 25.56 72.58 44.99
Low 20.90 12.73 31.25 21.76
7 day PAHs High 32.34 21.82 78.72 41.35
Low 11.86 6.23 24.07 12.21
doi:10.1371/journal.pone.0026589.t004
Table 5. Effects of dietary fish oil on hepatic gene expression
of some metabolic enzymes.
Gene Group Normalized DD Ct values P
CO (Mean±SEM) FO (Mean±SEM)
Cyp1a1* DMSO 5.3860.36 5.2860.13 0.903
HD PAHs 2.6960.07 6.3260.31 ,0.001
LD PAHs 3.5260.16 4.4160.12 0.038
Cyp1b1* DMSO 7.6660.60 7.7360.56 0.967
HD PAHs 8.6560.59 8.5860.45 0.963
LD PAHs 8.1960.54 9.8860.46 0.232
Gstt1** DMSO 8.2061.19 18.3863.63 0.037
HD PAHs 21.0362.60 27.0561.69 0.100
LD PAHs 15.0662.25 24.5861.61 0.014
Gstm1** DMSO 2.4060.26 2.6560.18 0.460
HD PAHs 7.376.11 8.2460.61 0.517
LD PAHs 2.7160.29 2.7460.33 0.947
*2‘(2(Ct value 2 b-actin value 2 15));
**2‘(2(Ct value 2 b-actin value 2 3));
n=4.
doi:10.1371/journal.pone.0026589.t005
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severe liver damage at 7 d after treatment in CO group (Figure 4),
but not in FO group. These results suggested that FO played a
protective role in liver against PAH toxicity at 7 d time point.
These results also support the hypothesis that detoxification of
carcinogenic PAHs by FO is one of pathways responsible for the
decreased hepatic DNA adducts in these mice.
FO may eliminate adducted nucleotides through increasing
apoptosis [16,48], inhibition of cell proliferation [19]. Although
dietary FO may reduce oxidative DNA damage [16,49,50] and
play a role as antioxidant in certain diseases [50], there is no direct
evidence to show that FO can enhance DNA repair activities, as
bulky DNA adducts are formed by exposure of chemical
carcinogens at early stages, such as at 7 d. It has been reported
that n-3 fatty acids decrease cell growth [51] and induce apoptosis
in many human cancer cells [40] such as colonic [52], prostate
[53], pancreatic [54], pulmonary [19], and breast cancers [55].
We have also reported [14] that retinoic acid, which could be a
suppressing agent [42], diminishes BaP-adducts in HepG2 cells
partially by inducing apoptosis. However, n-3 fatty acids did not
induce significant apoptosis in our current animal experiments.
Apoptosis may be a secondary reaction of protection when animals
are exposed to chemical toxicants. Therefore, this protective
approach may be observed after 7 d of the PAH treatment.
As one of the natural chemopreventive agents, FO containing n-
3 fatty acids has received great attention for cancer prevention
because of its various health benefits, lack of toxicity and less side
effects [10]. Although the contents of FO in diet were quite high
(11.5%), it may not be attained in human population. Yam et al
[20] reported that 4% FO could also suppress tumor growth and
metastasis. In the future studies, long term regimen and lower
concentration of FO should be investigated in cancer prevention.
As mentioned in the Introduction, natural chemopreventive agents
prevent chemical carcinogenesis mainly through three pathways,
i.e. detoxification, DNA repair, and apoptosis. Different natural
product may have different pathway(s) against chemical carcino-
genesis. To increase the efficiency in chemoprevention in high risk
population, the combination of natural chemopreventive agents
may provide potential and efficient benefits in cancer prevention,
especially in chemical carcinogenesis.
In conclusion, our results showed that FO significantly deceased
levels of both BPDE-dG and total PAH DNA adducts in the liver of
B6C3F1 male mice at 7 d after treatment of carcinogenic PAHs.
Also, FO significantly enhanced expression of Cyp1a1 and Gstt1
genes (low dose of PAHs) at 7 d after PAH treatment. Histological
observation indicated that FO protected liver against PAH toxicity.
Further studies could lead to the development of novel strategies
(e.g., dietary FO, or combination of chemopreventive agents) in the
prevention of human cancers caused by environmental PAHs.
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